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G
lycated hemoglobin concentrations
(most commonly hemoglobin A1C;
HbA1c) reﬂect time-averaged blood
glucose during the previous 2–3 months
andareusedasthegoldstandardforlong-
term follow-up of glycemic control. Stan-
dardizationwithcommoncalibrationwas
ﬁrst proposed in 1984 (1). It was only
after the publication of the Diabetes Con-
trol and Complications Trial (DCCT)
study in 1993 (2), however, that the issue
of international standardization of HbA1c
measurements became an important ob-
jectiveforscientistsandclinicians.Atthat
time, the lack of international standard-
ization resulted in several countries devel-
oping National standardization programs;
most notable of these are:
● in the U.S., the National Glycohemo-
globin Standardization Program
(NGSP), with the DCCT HPLC method
used as the primary reference method;
● in Sweden, with the Mono S ion ex-
change chromatography designated as
the comparison method;
● in Japan, with use of common calibra-
tors (six calibrators available for use)
with HbA1c values assigned by the Ja-
pan Diabetes Society.
A common feature of these national pro-
grams is the absence of primary and sec-
ondary reference materials. To overcome
this lack of reference materials, achieve
global standardization, and meet the re-
quirements of the European Union direc-
tive on in vitro diagnostic (IVD) medical
devices, the International Federation of
Clinical Chemistry and Laboratory Medi-
cine(IFCC)establishedaWorkingGroup
on HbA1c Standardization to develop a
referencemeasurementsystemwithinthe
concept of metrological traceability. Such
asystemhasbeendevelopedconsistingof
incubationwiththeenzymeendoprotein-
ase Glu-C, cleavage of the NH2-terminal
hexapeptide of the -chain, and separa-
tion and quantiﬁcation of glycated and
nonglycated hexapeptides by mass spec-
trometry or capillary electrophoresis (3).
The analyte measured is a hemoglobin
molecule having a stable adduct of glu-
cose to the NH2-terminal valine of the he-
moglobin -chain (N-1-deoxyfructosyl-
hemoglobin). Pure HbA1c and pure HbA0
areisolatedfromhumanbloodandmixed
in well-deﬁned proportions to produce a
certiﬁed primary reference material set
used to calibrate the primary reference
measurement system (PRMS). The PRMS
valuesareassignedtosecondaryreference
materials (SRMs; whole blood), and the
SRMs are used by the manufacturers to
calibrate their instruments. A laboratory
network has been established to imple-
ment and maintain the PRMS (4).
Adopting the new IFCC standardiza-
tion procedure will result in HbA1c per-
centage values being lowered due to the
higher speciﬁcity on the reference
method.Ithasbeensuggestedthatlower-
ing the percentage value of the HbA1c re-
ported may lead to poorer glycemic
control in some patients (5), and IFCC
has recommended the use of SI (Syste `me
International) units of mmol/mol, which
would minimize the risk of confusion be-
tween IFCC percentage units and DCCT/
NGSP percentage units (6).
Expressing HbA1c as an average glu-
cose concentration has been widely dis-
cussed, as there is a convincing linear
relationship between HbA1c and average
glucose concentration in both adults (7)
and children (8). Nevertheless, not all
population groups have been evaluated
adequately.
Clinicians and scientists have unani-
mouslywelcomedtheuseoftheIFCCref-
erence method for calibration purposes,
and the implementation of this standard-
izationprocessisongoing.Therehasbeen
a considerable debate, however, regard-
ingthenumberissue,i.e.,whetherHbA1c
should be expressed in percentage units
related to the DCCT study or mmol/mol
related to the IFCC method. There is an
evident need to keep doctors, nurses, and
peoplewithdiabeteseducatedtoensurea
worldwide understanding of previously
reported and upcoming scientiﬁc HbA1c
results. A ﬁrst consensus meeting was
held in 2007 (9–10), where it was de-
cided that the new IFCC reference system
for HbA1c represents the only valid an-
chor to implement standardization of the
measurement, and that HbA1c results
were to be reported worldwide in IFCC
units (mmol/mol) and derived NGSP
units (%), using the IFCC-NGSP master
equation.
Asecondconsensusmeetingwasheld
at the International Diabetes Federation
(IDF) meeting in Montreal on 21 October
2009.TheAmericanDiabetesAssociation
(ADA), the European Association for the
Study of Diabetes (EASD), the IDF, the
IFCC, and the International Society for
Pediatric and Adolescent Diabetes
(ISPAD) were represented at that meet-
ing, as well as some editors from medical
journals, and the following statements
were approved by these organizations:
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ized worldwide, including the refer-
ence system and results reporting.
2. The IFCC reference system for HbA1c
represents the only valid anchor to
implement standardization of the
measurement.
3. HbA1c results are to be reported by
clinical laboratories worldwide in SI
(Syste `me International) units (mmol/
mol, no decimals) and derived NGSP
units (%, one decimal), using the
IFCC-NGSP master equation (DCCT
units).
4. HbA1c conversion tables including
bothSI(IFCC)andNGSP/DCCTunits
should be easily accessible to the dia-
betes community.
5. Editors of journals and other printed
material are strongly recommended to
require that submitted manuscripts
report HbA1c in both SI (IFCC) and
NGSP/DCCT units.
6. The reportable term for glycated he-
moglobinisHbA1c,althoughotherab-
breviations may be used in guidelines
and educational material (A1C).
7. The above consensus recommenda-
tions apply through 2011, when they
willbediscussedagainatthenextcon-
sensus meeting at the IDF meeting in
Dubai, December 2011.
HbA1c-derived average glucose values
(ADAGs) calculated from the HbA1c re-
sults were not included in the consensus
duetotheabove-mentionedlimitationsof
this procedure. However, the use of an
estimated average glucose (eAG) (7) in
discussionwithanindividualpatientmay
add to the consultation process, and the
availability of such estimation may be ad-
vantageous. Agreement should be
reached at a local level on how to make
this estimation available.
In a world of increased communica-
tion, and with the ever-increasing avail-
abilityofinformationthatbothlaypeople
and professionals may access via the In-
ternet,itisinevitablethatscientiﬁcresults
from studies such as the DCCT will be
brought to the attention of interested in-
dividuals for decades to come. By report-
ing in both IFCC and DCCT units,
ongoing continuity between these report-
ing systems will be ensured. The submis-
sionofmanuscriptscontainingbothunits
will facilitate the alignment of the various
HbA1c methods, as the master equation
willbeusedinthelaboratoryinstruments
for calculating the DCCT units, i.e., both
the IFCC units and the DCCT units will
have the same basis. It is therefore of vital
importance that all laboratories and other
users of instruments for measuring
HbA1c, either in the laboratory or at the
point of care, take part in quality control
and quality assessment programs to en-
sureaccurateresults(individualcountries
willvaryinthewaythisisperformed).We
hopethattherecommendationofdualre-
porting in submitted manuscripts will be
adopted promptly by all scientiﬁc jour-
nals publishing diabetes articles.
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